Jazz Pharmaceuticals (JAZZ) FCF Margin (2010 - 2026)

Jazz Pharmaceuticals' FCF Margin history runs 17 years deep, the most recent figure standing at 30.97% for Q1 2026.

• In Q1 2026, FCF Margin fell 1536.0% year-over-year to 30.97%; the TTM figure through Mar 2026 stood at 27.31% (down 1086.0% YoY), while the FY2025 annual figure was 30.39%, down 391.0% from the prior year.
• FCF Margin was 30.97% for Q1 2026 at Jazz Pharmaceuticals, up from 28.87% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 114.61% in Q3 2025 to a low of 72.23% in Q2 2025.
• Historically, FCF Margin has averaged 31.29% across 5 years, with a median of 31.17% in 2022.
• Biggest YoY gain for FCF Margin was 7549 bps in 2025; the steepest drop was 10390 bps in 2025.
• A 5-year view of FCF Margin shows it stood at 34.21% in 2022, then sank by 55 bps to 15.54% in 2023, then soared by 136 bps to 36.63% in 2024, then dropped by 21 bps to 28.87% in 2025, then advanced by 7 bps to 30.97% in 2026.
• The last three FCF Margin figures came in at 30.97% (Q1 2026), 28.87% (Q4 2025), and 114.61% (Q3 2025), per Business Quant data.